Latham & Watkins advises NextRoll in US$50 million financing deal from Capital IP. NextRoll, the San Francisco-based marketing technology company delivering products for ambitious marketers to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Adept in the fundraising round. Adept announced $350 million of new capital as part of a Series B led by General Catalyst and co-led...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Believer Entertainment on the financing. Believer Entertainment, founded by industry veterans obsessed with players and creating worlds worthy of them, announced that...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented KLYM in the transaction. KLYM (previously OmniLatam), a leading fintech company with operations in Colombia, Chile, and Brazil, announced the closing of its US$27...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented CG Oncology in the transaction. CG Oncology, Inc., an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Point in the transaction. Point, a fintech company and home equity platform that provides homeowners access to equity financing in exchange for...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented SoftBank Vision Fund 2 in the transaction. Spotter, the creator platform, announced US$200 million in Series D financing at a valuation of US$1.7...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented SoftBank Vision Fund 2 in the transaction. Big Health, a digital therapeutics company dedicated to helping millions get back to good mental health,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented SoftBank Vision Fund 2 in the transaction. SambaNova Systems, the company building advanced software, hardware and services to run AI applications,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Crossover Health in the transaction. Crossover Health, a relationship-based, tech-enabled, national healthcare organization that integrates both virtual and in-person care for...
You must be a Standard 1 Year member to access this content.
